Interaction between &bgr;2 adrenergic receptor polymorphisms determines the extent of isoproterenol-induced vasodilatation ex vivo

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Pharmacogenetics & Genomics

• Publication date

  2007-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/FPC.0b013e3281eb8f07PMID 17885618
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Statins and the endothelium.

  2007cited by this paper
• Association between insulin resistance and endothelial dysfunction in type 2 diabetes and the effects of pioglitazone.

  2007cited by this paper
• Molecular mechanisms of beta(2)-adrenergic receptor function, response, and regulation.

  2006cited by this paper
• Molecular mechanisms of β2-adrenergic receptor function, response, and regulation

  2006cited by this paper
• Human β2‐adrenergic receptor gene haplotypes and venodilation in vivo

  2005cited by this paper
• Drug metabolism and variability among patients in drug response.

  2005cited by this paper
• Beta2-adrenoceptor polymorphisms relate to insulin resistance and sympathetic overactivity as early markers of metabolic disease in nonobese, normotensive individuals.

  2005cited by this paper
• Pharmacogenetics – five decades of therapeutic lessons from genetic diversity

  2004cited by this paper
• The Arg389Gly beta1-adrenoceptor gene polymorphism determines contractile response to catecholamines.

  2004cited by this paper
• Genotype Gly/Gly of the Arg16Gly polymorphism of the beta2-adrenergic receptor is associated with elevated fasting serum insulin concentrations, but not with acute insulin response to glucose, in type 2 diabetic patients.

  2004cited by this paper
• Pharmacogenomics of adrenoceptors.

  2004cited by this paper
• Beta-adrenoceptor polymorphisms.

  2004cited by this paper
• Drug receptor/effector polymorphisms and pharmacogenetics: current status and challenges.

  2003cited by this paper
• β2‐Adrenergic receptor polymorphism and nitric oxide‐dependent forearm blood flow responses to isoproterenol in humans

  2003cited by this paper
• Beta(2)-adrenergic receptor polymorphism and nitric oxide-dependent forearm blood flow responses to isoproterenol in humans.

  2003cited by this paper
• β-Adrenoceptor polymorphisms

  2003cited by this paper
• Beta2 adrenoceptor THR164ILE polymorphism is associated with markedly decreased vasodilator and increased vasoconstrictor sensitivity in vivo

  2003cited by this paper
• Pharmacology and physiology of human adrenergic receptor polymorphisms.

  2003cited by this paper
• Genotype‐dependent time course of lymphocyte β2‐adrenergic receptor down‐regulation

  2003cited by this paper
• An Ile to Met polymorphism in the catalytic domain of adenylyl cyclase type 9 confers reduced beta2-adrenergic receptor stimulation.

  2003cited by this paper
• The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization.

  2001cited by this paper
• β2-Adrenergic Receptor Genotype-Related Changes in cAMP Levels in Peripheral Blood Mononuclear Cells After Multiple-Dose Oral Procaterol

  2001cited by this paper
• Techniques to study the pharmacodynamics of isolated large and small blood vessels.

  2000cited by this paper
• &bgr;2-Adrenoceptor Polymorphism Determines Vascular Reactivity in Humans

  2000cited by this paper
• Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness.

  2000cited by this paper
• beta2-adrenergic receptor polymorphisms at amino acid 16 differentially influence agonist-stimulated blood pressure and peripheral blood flow in normal individuals.

  2000cited by this paper
• beta-2 Adrenergic receptor variants affect resting blood pressure and agonist-induced vasodilation in young adult Caucasians.

  1999cited by this paper
• Nifedipine improves endothelial function in hypercholesterolemia, independently of an effect on blood pressure or plasma lipids.

  1999cited by this paper
• Population frequency, mutation linkage and analytical methodology for the Arg16Gly, Gln27Glu and Thr164Ile polymorphisms in the beta2-adrenergic receptor among Turks.

  1999cited by this paper
• Frequency of functionally important beta-2 adrenoceptor polymorphisms varies markedly among African-American, Caucasian and Chinese individuals.

  1999cited by this paper
• Endothelial dysfunction in human intramyocardial small arteries in atherosclerosis and hypercholesterolemia.

  1998cited by this paper
• Endothelial dysfunction in human intramyocardial small arteries in atherosclerosis and hypercholesterolemia.

  1998cited by this paper
• Insulin modulation of an endothelial nitric oxide component present in the alpha2- and beta-adrenergic responses in human forearm.

  1997cited by this paper
• Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study.

  1996cited by this paper
• Angiotensin Converting Enzyme Inhibition, with Quinapril, Improves Endothelial Vasomotor Dysfunction in Patients with Coronary Artery Disease: the TREND Study (Trial on REversing ENdothelial Dysfunction)

  1996cited by this paper
• Influence of beta 2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells.

  1995cited by this paper
• Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties.

  1994cited by this paper
• Cigarette Smoking Is Associated With Dose‐Related and Potentially Reversible Impairment of Endothelium‐Dependent Dilation in Healthy Young Adults

  1993cited by this paper
• Mutations in the gene encoding for the beta 2-adrenergic receptor in normal and asthmatic subjects.

  1993cited by this paper
• Incidence of atherosclerosis in the internal mammary artery.

  1989cited by this paper

• The Adrenergic System in Cardiovascular Metabolism and Aging

  2015cites this paper
• The Adrenergic System in Vascular Endothelial Cells

  2015cites this paper
• The future of pharmacogenetics in the treatment of heart failure.

  2015cites this paper
• Polymorphic Variants of Adrenoceptors: Pharmacology, Physiology, and Role in Disease

  2014cites this paper
• State of play of pharmacogenetics and personalized medicine in heart failure.

  2013cites this paper
• G-Protein-Coupled Receptor Kinase 2 and Hypertension

  2013cites this paper
• Very important pharmacogene summary ADRB2

  2010cites this paper
• Enhanced GRK2 Expression and Desensitization of βAR Vasodilatation in Hypertensive Patients

  2008cites this paper